Angela G. Fleischman

Hematology | Oncology
101 The City Drive South
Building 23
Orange, CA 92868

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Cigarette Smoke and E-Cigarette Aerosol Extracts Induce Myelopoiesis and Suppress Inflammatory Cytokine Production.

Cigarette Smoke and E-Cigarette Aerosol Extracts Induce Myelopoiesis and Suppress Inflammatory Cytokine Production.

Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: September 04, 2026

Beyond triple-negative: germline MPL and SH2B3/LNK mutations reshape the genetic landscape of hereditary thrombocytosis.

Beyond triple-negative: germline MPL and SH2B3/LNK mutations reshape the genetic landscape of hereditary thrombocytosis.

Journal: Haematologica
Published: August 06, 2026

Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors.

Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors.

Journal: BMC cancer
Published: May 08, 2026

Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis.

Leveraging Dietary Interventions to Benefit Patients with Hematologic Malignancies and Clonal Hematopoiesis.

Journal: Nutrients
Published: March 19, 2026

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Sapablursen for Erythrocytosis Control in Patients with Polycythemia Vera.

Journal: Blood
Published: March 13, 2026

A niche for every stem cell in myeloproliferative neoplasms.

A niche for every stem cell in myeloproliferative neoplasms.

Journal: Blood
Published: March 12, 2026

Telehealth-Delivered Dietary Counseling in Myeloproliferative Neoplasms: A Randomized Feasibility Study.

Telehealth-Delivered Dietary Counseling in Myeloproliferative Neoplasms: A Randomized Feasibility Study.

Journal: Nutrients
Published: March 07, 2026

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation.

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validation.

Journal: Nano convergence
Published: February 13, 2026

The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes.

The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes.

Journal: Current hematologic malignancy reports
Published: December 02, 2025

Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Impaired IL-10 Receptor Signaling Leads to Inflammation Induced Exhaustion in Hematopoietic Stem Cells.

Impaired IL-10 Receptor Signaling Leads to Inflammation Induced Exhaustion in Hematopoietic Stem Cells.

Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia: Computational target analysis and therapeutic validation.

Multimodal gene and targeted drug therapy for chronic myelogenous leukemia: Computational target analysis and therapeutic validation.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Showing 1-12 of 68

Last Updated: 09/26/2026